| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | Nov 12, 2024 | ||
| SC 13G/A | Report | Nov 4, 2024 | ||
| SC 13G | Report | SC 13G | Feb 14, 2024 | |
| SC 13G | Report | Jan 29, 2024 | ||
| SC 13G | Report | Jul 8, 2022 | ||
| SC 13G | Report | Feb 4, 2022 | ||
| SC 13G/A | Report | SC 13G/A | Jan 12, 2022 | |
| SC 13G/A | Report | KEMPHARM, INC. | Jan 11, 2022 | |
| SC 13G/A | Report | AMENDMENT NO. 1 | May 17, 2021 | |
| SC 13G | Report | SC 13G | Apr 19, 2021 | |
| SC 13G/A | Report | AMENDMENT NO. 2 TO SCHEDULE 13G | Mar 9, 2021 | |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G/A | Report | Feb 12, 2021 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 12, 2021 | |
| SC 13G | Report | Feb 5, 2021 | ||
| SC 13G | Report | KEMPHARM, INC. | Jan 14, 2021 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 14, 2020 | |
| SC 13G/A | Report | Feb 14, 2020 | ||
| SC 13G/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13G | Feb 11, 2020 | |
| SC 13G | Report | Jun 11, 2019 | ||
| SC 13G/A | Report | Feb 14, 2019 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 11, 2019 | |
| SC 13G/A | Report | SC 13G/A | Jan 17, 2019 | |
| SC 13G/A | Report | Nov 21, 2018 | ||
| SC 13G/A | Report | Feb 14, 2018 | ||
| SC 13G/A | Report | Feb 14, 2018 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 12, 2018 | |
| SC 13G/A | Report | SC 13G/A | Jan 29, 2018 | |
| SC 13G/A | Report | SC 13G/A | Sep 15, 2017 | |
| SC 13G | Report | Feb 14, 2017 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 14, 2017 | |
| SC 13G/A | Report | Feb 14, 2017 | ||
| SC 13G/A | Report | Feb 10, 2017 | ||
| SC 13G/A | Report | SC 13G/A | Jan 10, 2017 | |
| SC 13G | Report | SC 13G | Feb 16, 2016 | |
| SC 13G/A | Report | Feb 16, 2016 | ||
| SC 13G/A | Report | Feb 16, 2016 | ||
| SC 13G/A | Report | SC 13G/A | Feb 11, 2016 | |
| SC 13G/A | Report | Dec 18, 2015 | ||
| SC 13G | Report | SC 13G | Oct 28, 2015 | |
| SC 13G | Report | Apr 29, 2015 | ||
| SC 13G | Report | Apr 23, 2015 |